Læknablaðið

Ukioqatigiit

Læknablaðið - 15.02.1998, Qupperneq 30

Læknablaðið - 15.02.1998, Qupperneq 30
118 LÆKNABLAÐIÐ 1998; 84 Wilmsæxli á íslandi Afturskyggn rannsókn tímabilið 1961-1995 Ingólfur Einarsson”, Tómas Guðbjartsson2’, Guðmundur Vikar Einarsson2-31, Jóhann Heiðar Jóhannsson41, Guðmundur K. Jónmundsson", Guðmundur Bjarnason" Einarsson I, Guðbjartsson T, Einarsson GV, Jó- hannsson JH, Jónmundsson GK, Hjarnason G Wilms’ tumor in Iceland 1961-1995. A retrospect- ive study Læknablaðið 1998; 84: 118-24 Objective: Wilms’ tumor is a malignant disease in the kidneys that usually affects young children. In- formation about the clinical behaviour of this tumor in Iceland has been scarce. The aim of this study was to find the incidence, clinical presentation, treatment and survival of patients with Wilms’ tumor. Material and methods: Included in the study were all patients diagnosed with Wilms’ tumor in Iceland from lstof January 1961 to 31 st of December 1995. Altogether, there were 17 patients, 15 children, mean age 33 months (standard deviation 19, range 5-77 months) and two adults (age 25 and 29), with M/F ratio 0.7. Information was gained from each patient’s record and the cancer registry of the Icelandic Cancer Society. All the tumors were re-evaluated by a pathologist and staged according to the NWTS staging system. Results: Age adjusted incidence during the study period was 0.2/100,000 per year (1.0 for children under 15 years). Abdominal mass (65%) and abdom- inal pain (53%) were the most common symptoms. Histology was typical in all cases except one with anaplasia and another with sarcomatous growth. One patient was diagnosed in stage I (6%), six in stage II (35%) and seven in stage III (41%). Two patients had pulmonary metastases (stage IV) and one had bilater- al tumor (stage V). Nephrectomy was performed in Frá "Barnaspítala Hringsins, "handlækninga- og þvag- færaskurðdeild Landspítalans, 3llæknadeild Háskóla ís- lands, ‘"Rannsóknastofu Háskóla íslands í meinafræði. Fyrirspurnir, bréfaskipti: Ingólfur Einarsson, Holtsgötu 17, 101 Reykjavík. Lykilorð: Wilmsæxli, nýgengi, lifun. all cases. The operative mortality was 12%. Of the 15 patients surviving surgery, 12 received radiotherapy, 12 chemotherapy and nine both treatments. Crude five-year-survival for the whole group was 42%, 25% for the patients diagnosed 1961-1976 and 61% for those diagnosed 1977-1995 (p=0.13). The patient with bilateral tumor was still alive 13 years after di- agnosis. Conclusion: As in other Western countries, Wilms’ tumor is rare in Iceland and has similar incidence and clinical presentation. Two thirds of the patients were diagnosed in stage II or III. Even patients with dis- tant metastases can be cured with multimodal treat- ment: surgery, chemotherapy and radiotherapy. There was a trend toward better survival during the study period. From ''Dpt. of Pediatrics, 2|Dpt. of Surgery, 3|University of lceland, Faculty of Medicine, 4lDpt. of Pathology. Land- spítalinn, University Hospital, 101 Reykjavík, lceland. Key words: Wilms’ tumor, incidence, survival. Ágrip Tilgangur: Wilmsæxli er illkynja sjúkdóm- ur í nýrum og greinist yfirleitt hjá ungum börn- um. Lítið hefur verið ritað um sjúkdóminn hér á landi. Tilgangur þessarar afturskyggnu rann- sóknar var að kanna faraldsfræði Wilmsæxla á Islandi, sjúkdómseinkenni, meðferð og lífs- horfur sjúklinganna. Efniviður og aðferðir: Alls greindust 17 einstaklingar, 15 börn og tveir fullorðnir (25 og 29 ára) á tímabilinu 1. janúar 1961 til 31. des- ember 1995, samkvæmt krabbameinsskrá Krabbameinsfélags Islands. Meðalaldur barn- anna var 33 mánuðir (staðalfrávik 19, bil 5-77 mánuðir). Upplýsingar um einkenni, niðurstöð- ur rannsókna og meðferð fengust úr sjúkra- skrám. Öll vefjasýnin voru yfirfarin og æxlin stiguð (National Wilms’ Tumor Study, NWTS flokkun).
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100

x

Læknablaðið

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.